Clinical Credibility 2Morrow offers an evidence-based tobacco cessation solution (Breathe Bundle) backed by multiple peer-reviewed studies and a Phase III randomized trial, led by a clinician-research leader with NIH grant experience. The platform has scaled to 70+ enterprise clients and over a million users, creating a strong ROI narrative for enterprise buyers focused on verified health outcomes and cost savings.

Public Sector Advantage Its public health and payer orientation is demonstrated by partnerships with the Washington State Department of Health and other public health agencies. This positions 2Morrow to pursue additional government sponsorships and health-plan opportunities, especially where digital interventions with proven outcomes are mandated.

Security & Interop Security and interoperability are core differentiators: SOC 2 Type II certified and HIPAA compliant, with secure SSO and API integrations. The platform is designed to plug into benefits ecosystems and health systems, including potential connections with Spring Health and Castlight Health, reducing IT risk for large employers.

Strategic Partnerships B2B-only model with 70+ enterprise clients including Fortune 500 employers, health plans, brokerages, and health systems. A track record of high-profile collaborations (GSK, Fred Hutch) and MedTech recognition supports co-selling and multi-customer deals.

Product Expandability Two bundles enable cross-sell into a holistic employee wellness program—Breathe Bundle for tobacco cessation and Wellbeing Bundle for stress, weight, chronic pain and healthy habits—delivered via a private mobile app with health coaching. Potential to expand into ACT-based digital therapeutics for chronic pain and broader workplace health initiatives.